Amarantus BioScience Holdings, Inc. (AMBS)

AMBS Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2018	FY 2017	FY 2015	FY 2014	FY 2013
Period Ending	Jun 30, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Selling, General & Admin	1.38	3.04	3.26	11.97	7.74	3.65
Research & Development	0	0	0	12.85	13.61	2.06
Operating Expenses	1.38	3.04	3.26	24.82	21.35	5.71
Operating Income	-1.38	-3.04	-3.26	-24.82	-21.35	-5.71
Interest Expense	-0	-0.96	-1.42	-2.23	-0.81	-2.63
Interest & Investment Income	0.06	0.03	0.05	-	-	-
Other Non Operating Income (Expenses)	-	-	-0	2.46	-3.86	0.27
EBT Excluding Unusual Items	-1.32	-3.97	-4.63	-24.59	-26.03	-8.07
Gain (Loss) on Sale of Investments	-6.62	-6.62	-	-	-	-
Other Unusual Items	-	-	-	-0.63	-1.25	-7.06
Pretax Income	-7.94	-10.58	-4.63	-25.21	-27.28	-15.13
Net Income	-7.94	-10.58	-4.63	-25.21	-27.28	-15.13
Preferred Dividends & Other Adjustments	-	-	-	11.84	0.88	0.04
Net Income to Common	-7.94	-10.58	-4.63	-37.06	-28.15	-15.17
Shares Outstanding (Basic)	253	234	-	9	5	3
Shares Outstanding (Diluted)	253	234	-	9	5	3
Shares Change (YoY)	1529.07%	-	-	80.21%	63.87%	220.47%
EPS (Basic)	-0.03	-0.05	-	-4.17	-5.71	-5.05
EPS (Diluted)	-0.03	-0.05	-	-4.17	-5.71	-5.05
Free Cash Flow	-5.47	-1.8	-0.86	-16.02	-11.51	-3.47
Free Cash Flow Per Share	-0.02	-0.01	-	-1.80	-2.34	-1.16
EBITDA	-	-	-	-24.65	-21.2	-5.64
D&A For EBITDA	-	-	-	0.18	0.15	0.07
EBIT	-1.38	-3.04	-3.26	-24.82	-21.35	-5.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.